Nicholas Benedict

Global Head of Anti-Infectives Business Unit at Novartis AG

Nicholas Benedict

Nicholas Benedict

Global Head of Anti-Infectives Business Unit at Novartis AG

Overview
Career Highlights

Novartis Corporation
Lumavita AG
Allecra Therapeutics GmbH

RelSci Relationships

1635

Relationships
RelSci Relationships are individuals Nicholas Benedict likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former Chief Operating Officer at Novartis Corporation

Relationship likelihood: Strong

Executive Partner at MPM Capital Inc

Relationship likelihood: Strong

Chief Executive Officer at Implenia AG

Relationship likelihood: Strong

Chief Executive Officer at Novartis AG

Relationship likelihood: Strong

Chief Financial Officer at Novartis AG

Relationship likelihood: Strong

Chief People & Organization Officer at Novartis AG

Relationship likelihood: Strong

General Manager Region Europe Oncology at Novartis Venture Fund

Relationship likelihood: Strong

President at Novartis Institutes for BioMedical Research, Inc.

Relationship likelihood: Strong

Chief Executive Officer, Sandoz at Novartis AG

Relationship likelihood: Strong

Former Chairman at Novartis AG

Relationship likelihood: Strong

Paths to Nicholas Benedict
Potential Connections via
Relationship Science
You
Nicholas Benedict
Global Head of Anti-Infectives Business Unit at Novartis AG
Education
BA Unknown

King's College London was founded by King George IV and the Duke of Wellington (then Prime Minister) in 1829 as a university college in the tradition of the Church of England. It now welcomes staff and students of all faiths and beliefs.

The University of Manchester (UoM) is a large research university situated in the city of Manchester, England. Manchester University - as it is commonly known - is a public university formed in 2004 by the merger of the University of Manchester Institute of Science and Technology (est. 1824) and the Victoria University of Manchester (est. 1851). Manchester is a member of the worldwide Universities Research Association group, the Russell Group of British research universities and the N8 Group. The University of Manchester is regarded as a "red brick university", and was a product of the civic university movement of the late 19th century. It formed a constituent part of the federal Victoria University between 1880, when it received its royal charter, and 1903-1904, when it was dissolved. The main campus is south of Manchester city centre on Oxford Road. In 2012, the university had around 39,000 students and 10,400 staff, making it the largest single-site university in the United Kingdom.[5] The University of Manchester had an income of £827 million in 2012–13, of which £200 million was from research grants and contracts.[6] In the 2008 Research Assessment Exercise,[7] Manchester came third in terms of research power and eighth for grade point average quality when including specialist institutions.[8] More students try to gain entry to the University of Manchester than to any other university in the country, with more than 60,000 applications for undergraduate courses.[9] According to the 2012 Highfliers Report, Manchester is the most targeted university by the Top 100 Graduate Employers.[10][11] In the 2012 Academic Ranking of World Universities, Manchester is ranked 40th in the world and 5th in the UK.[12] It is ranked 58th in the world and 12th in Europe in the 2014 Times Higher Education World University Rankings.[13] The university owns and operates major cultural assets such as the Manchester Museum, Whitworth Art Gallery, John Rylands Library and Jodrell Bank Observatory. The University of Manchester has 25 Nobel Laureates among its past and present students and staff, the third-highest number of any single university in the United Kingdom after Cambridge and Oxford. Four Nobel laureates are currently among its staff – more than any other British university.

MBA Unknown

Alliance Manchester Business School is the business school of the University of Manchester in Manchester, England.

Career History
Global Head of Anti-Infectives Business Unit
Tenure Unconfirmed

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Tenure Unconfirmed

Roche Holding ag Roche Personalised Healthcare – our mission The healthcare landscape is constantly changing. Patients, physicians and payers demand safer, more effective treatments, while investors search after robust and sustainable business models. Growing demand for highly effective, impactful medicines is being driven by an aging population, healthcare and economic pressures. But an influx of new technologies enables Roche to meet this need by offering innovative tests and medicines. These healthcare drivers have led us in one direction – ‘Roche Personalised Healthcare’. At Roche, ‘Personalised Healthcare’ is at the core of our business strategy

Team Member
Tenure Unconfirmed

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Investments
Details Hidden

Allecra Therapeutics GmbH focuses on the development of novel treatments to combat multi drug-resistant bacterial infections. The firm serves the bio and pharmaceutical industry. The company was founded by Nicholas Benedict and Stuart Shapiro in 2013 and is headquartered in Weil am Rhein, Germany.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Nicholas Benedict. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Nicholas Benedict's profile does not indicate a business or promotional relationship of any kind between RelSci and Nicholas Benedict.